Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score

Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score

Background: The advent of immune checkpoint inhibitors (ICIs) has revolutionized the metastatic renal cell carcinoma (mRCC) therapeutic landscape. Nevertheless, tyrosine-kinase inhibitors (TKIs) targeting the vascular endothelial growth factor (VEGF) axis still play a key role. The aim of the presen...

Full description

Bibliographic Details
Main Authors: Giulia Mazzaschi, Alessandro Lazzarin, Matteo Santoni, Francesca Trentini, Ugo De Giorgi, Nicole Brighi, Chiara Tommasi, Silvia Puglisi, Orazio Caffo, Stefania Kinspergher, Alessia Mennitto, Carlo Cattrini, Elena Verzoni, Alessandro Rametta, Marco Stellato, Andrea Malgeri, Giandomenico Roviello, Enrico Maria Silini, Pasquale Rescigno, Sara Elena Rebuzzi, Giuseppe Fornarini, Federico Quaini, Giulia Claire Giudice, Giuseppe Luigi Banna, Sebastiano Buti
Format: Article
Language:English
Published: IMR Press 2023-07-01
Series:Frontiers in Bioscience-Elite
Subjects:
metastatic renal cell carcinoma (mrcc)
macrocytosis
anisocytosis
anemia
hif
tyrosine-kinase inhibitors
prognostic score
mcv
hb
rdw
Online Access:https://www.imrpress.com/journal/FBE/15/3/10.31083/j.fbe1503020

Internet

https://www.imrpress.com/journal/FBE/15/3/10.31083/j.fbe1503020

Similar Items